Myricx Bio
UKEntry
2024
Hold
2yr
Exit
2026
Who owns Myricx Bio?
Myricx Bio was owned by Abingworth through Abingworth Bioventures 8 (2021 vintage) from 2024 to 2026, exited via Trade Sale. Across its history, Myricx Bio has been through 3 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
AbingworthAbingworth Bioventures 8 · 2021 · Life Sciences VC
3 ownership periods · full history below
Key facts
Key takeaways
- ·Fully exited in 2026.
- ·Average hold across 3 realized cycles: 3 years.
Ownership history
3 ownership periods · co-invest detected
Exited
Last exited in 2026 to .
Co-invest · 3 holders · 2022 · 2026
Sofinnova PartnersExited 2026
2022 · 2026(4yr) · Sofinnova Capital X · 2021 · Life Sciences VC
Trade Sale · to
MOIC
–
AbingworthExited 2026
2024 · 2026(2yr) · Abingworth Bioventures 8 · 2021 · Life Sciences VC
Trade Sale · to
MOIC
–
Novo HoldingsExited 2026
2024 · 2026(2yr) · Novo Holdings Venture Investments · 1999 · VC
Trade Sale · to
MOIC
–
More from Abingworth Bioventures 8
Other portfolio companies in the same fund.
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Myricx Bio
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Myricx Bio?
2 strategic and 118financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Myricx Bio.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue